Skip to main page content
HOME
CURRENT ISSUE
ARCHIVE
FEEDBACK
SUBSCRIPTIONS
ALERTS
HELP
Keywords
GO
Advanced »
Institution: Stanford Univ Med Ctr Lane Med Lib/Periodical Dept/Rm L109
Sign In as Member / Individual
User Name
Password
Sign In
The Pharmocogenomics of Warfarin
Table 1.
Non-Synonymous Mutations in
VKORC1
Leading to Warfarin Resistance
Amino acid change
Daily Dose
Resistance Phenotype
Reference
Val
29
→ Leu
14 mg
Moderate
(
8
)
Ala
41
→ Ser
16 mg
(
9
)
Arg
58
→ Gly
32–36 mg
Major
(
8
)
Val
66
→ Met
27–35 mg
(
29
)
Leu
128
→ Arg
> 45 mg
Severe
(
8
,
30
)
Val
45
→ Ala
Target INR never reached
(
8
)
This Article
MI
August 2006
vol. 6
no. 4
223-227
Abstract
Free
Full Text
Full Text (PDF)
Current Issue
April 2011, 11 (2)
Alert me to new issues of MI
Instructions to Authors
About Molecular Interventions
Editorial Board
Subscription Information
Advertising
Terms, Conditions & Permissions Requests
RSS Feeds
Customized Alerts
All ASPET Journals
Molecular Pharmacology
Drug Metabolism and Disposition
J Pharmacology and Experimental Therapeutics
Pharmacological Reviews